Follow
Thiago Yukio Kikuchi Oliveira
Thiago Yukio Kikuchi Oliveira
Verified email at rockefeller.edu
Title
Cited by
Cited by
Year
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
DF Robbiani, C Gaebler, F Muecksch, JCC Lorenzi, Z Wang, A Cho, ...
Nature 584 (7821), 437-442, 2020
19552020
Evolution of antibody immunity to SARS-CoV-2
C Gaebler, Z Wang, JCC Lorenzi, F Muecksch, S Finkin, M Tokuyama, ...
Nature 591 (7851), 639-644, 2021
16442021
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Z Wang, F Schmidt, Y Weisblum, F Muecksch, CO Barnes, S Finkin, ...
Nature 592 (7855), 616-622, 2021
14492021
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding
JF Scheid, H Mouquet, B Ueberheide, R Diskin, F Klein, TYK Oliveira, ...
Science 333 (6049), 1633-1637, 2011
13352011
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
DH Barouch, JB Whitney, B Moldt, F Klein, TY Oliveira, J Liu, ...
Nature 503 (7475), 224-228, 2013
7882013
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Z Wang, F Muecksch, D Schaefer-Babajew, S Finkin, C Viant, C Gaebler, ...
Nature 595 (7867), 426-431, 2021
7132021
Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization
F Klein, R Diskin, JF Scheid, C Gaebler, H Mouquet, IS Georgiev, ...
Cell 153 (1), 126-138, 2013
6222013
Neuro-immune interactions drive tissue programming in intestinal macrophages
I Gabanyi, PA Muller, L Feighery, TY Oliveira, FA Costa-Pinto, D Mucida
Cell 164 (3), 378-391, 2016
5612016
HIV-1 integration landscape during latent and active infection
LB Cohn, IT Silva, TY Oliveira, RA Rosales, EH Parrish, GH Learn, ...
Cell 160 (3), 420-432, 2015
4822015
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
JF Scheid, JA Horwitz, Y Bar-On, EF Kreider, CL Lu, JCC Lorenzi, ...
Nature 535 (7613), 556-560, 2016
4732016
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
P Mendoza, H Gruell, L Nogueira, JA Pai, AL Butler, K Millard, ...
Nature 561 (7724), 479-484, 2018
4582018
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
M Caskey, T Schoofs, H Gruell, A Settler, T Karagounis, EF Kreider, ...
Nature medicine 23 (2), 185-191, 2017
4482017
Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching
M Di Virgilio, E Callen, A Yamane, W Zhang, M Jankovic, AD Gitlin, ...
Science 339 (6120), 711-715, 2013
4362013
Enhanced SARS-CoV-2 neutralization by dimeric IgA
Z Wang, JCC Lorenzi, F Muecksch, S Finkin, C Viant, C Gaebler, ...
Science translational medicine 13 (577), eabf1555, 2021
4102021
Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes
IA Klein, W Resch, M Jankovic, T Oliveira, A Yamane, H Nakahashi, ...
Cell 147 (1), 95-106, 2011
3812011
Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico
DF Robbiani, L Bozzacco, JR Keeffe, R Khouri, PC Olsen, A Gazumyan, ...
Cell 169 (4), 597-609. e11, 2017
3422017
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
T Schoofs, F Klein, M Braunschweig, EF Kreider, A Feldmann, L Nogueira, ...
Science 352 (6288), 997-1001, 2016
3322016
Sequential immunization elicits broadly neutralizing anti-HIV-1 antibodies in Ig knockin mice
A Escolano, JM Steichen, P Dosenovic, DW Kulp, J Golijanin, D Sok, ...
Cell 166 (6), 1445-1458. e12, 2016
3112016
Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow
J Lee, G Breton, TYK Oliveira, YJ Zhou, A Aljoufi, S Puhr, MJ Cameron, ...
Journal of Experimental Medicine 212 (3), 385-399, 2015
2992015
Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice
P Dosenovic, L von Boehmer, A Escolano, J Jardine, NT Freund, AD Gitlin, ...
Cell 161 (7), 1505-1515, 2015
2912015
The system can't perform the operation now. Try again later.
Articles 1–20